New research appearing in the Journal of the National Comprehensive Cancer Network found that incorporating information from ...

New research in the February 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans ...

These results suggest that oxybutynin may offer a practical and effective option for managing ADT-associated hot flashes in ...

Today, many men must choose between life-altering prostate removal or careful long-term monitoring. The EU-funded ROBIOSPY ...

An expanded collaboration between the two organizations will focus on prostate cancer and metastatic liver tumors, in addition to certain neurological disorders.

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

Men with prostate cancer who get hormone therapy experience hot flashes, where they experience intense and sudden heat and ...

Never miss an episode of Inspiring Wholeness, presented by AdventHealth in partnership with the Orlando Business Journal. Subscribe now on Apple Podcasts, Spotify or wherever you get your podcasts. In ...

UCLA researchers found that routine PSMA PET/CT scans could help doctors select treatment approaches for the best long-term outcomes in patients with recurring prostate cancer after surgical removal ...